Vulnerability identified for subtypes of glioblastoma
Glioblastoma, the most common and aggressive form of brain cancer, typically fails to respond to treatment or rapidly becomes drug ...
Glioblastoma, the most common and aggressive form of brain cancer, typically fails to respond to treatment or rapidly becomes drug ...
Credit: Credit: Michael Topper and Michelle Vaz Johns Hopkins Kimmel Cancer Center researchers and colleagues have identified a novel drug ...
Credit: Insilico Medicine Wednesday, Nov. 29, 2017, London, UK: Researchers from the Biogerontology Research Foundation, Insilico Medicine, Life Extension and ...
Credit: © Laurent Chatre - CNRS/Institut Pasteur Helicobacter pylori is a bacterial pathogen that colonizes the stomach of approximately half ...
Credit: Florida Atlantic University Too much, too little, just right. It might seem like a line from "Goldilocks and the ...
Credit: UC San Diego Health A team of University of California San Diego School of Medicine and Moores Cancer Center ...
Credit: Image courtesy of Dipanjan Pan CHAMPAIGN, Ill. -- University of Illinois researchers are sending tiny drug-laden nanoparticles on a ...
Credit: Insilico Medicine Wednesday, 22nd of November, 2017, Baltimore, MD, Insilico Medicine, a Baltimore-based next-generation artificial intelligence company specializing in ...
Credit: MPI f. Heart and Lung Research Shortness of breath and respiratory distress often increase the suffering of advanced-stage lung ...
In recognition of their contributions to basic, translational, and clinical research, six faculty members from The University of Texas MD ...
LUGANO, 20 November 2017 - Osimertinib improves progression-free survival compared to standard first line therapy in Asian patients with EGFR-mutated ...
A subanalysis of the phase III ALEX study has shown that alectinib (1) 600 mg twice daily is more effective ...
Credit: Rob O'Flanagan U of G scientists have made a discovery that could reduce the spread of cancer by hindering ...
Credit: Insilico Medicine, Inc. Wednesday, 15th of November, 2017, 10AM EST, Baltimore, MD, Insilico Medicine, a Baltimore-based next-generation artificial intelligence ...
The University of California, Davis, and the Leibniz Institute for Photonic Technologies in Jena, Germany, have entered an agreement of ...
(New York, NY - November 8, 2017)-- Researchers at the Icahn School of Medicine at Mount Sinai have created the ...
Credit: NIH Chronic inflammation is known to drive many cancers, especially liver cancer. Researchers have long thought that's because inflammation ...
Personalized medicine -- health care tailored to the individual patient -- not only involves the use of prescription medications but ...
SEATTLE -- Nov. 7, 2017 -- A new category of immunotherapies called checkpoint inhibitors that has been highly effective against ...
Credit: MD Anderson Cancer Center A study revealing a connection between circulating tumor cells (CTCs) and relapse in stage IV ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm' to start subscribing.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.